Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas

Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas have?

Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas has 52 citations in the OpenAlex counts ScholarIQ stores.

When was Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas published?

Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas has 2011 year in the ScholarIQ index.

What is the open-access status of Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas?

Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas has bronze oa status in the ScholarIQ index.

What is the DOI of Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas?

The DOI for Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas is on the source record.

What is the PMID of Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas?

The PMID for Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas is on the source record.

What is the OpenAlex record for Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas?

The OpenAlex for Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas is on the source record.